Intuitive Surgical Inc (NASDAQ:ISRG) had its stock rating reiterated as ‘Buy’ in a report released by analysts at Canaccord Genuity.
Canaccord Genuity today set a target price of 800 on the company’s stock. According to the analyst this now indicates there is a potential increase of 17.3% from Intuitive Surgical Inc’s current price of 682.
Over the last twelve months Intuitive Surgical Inc’s stock price has increased by 42.55% from 478.44 to 682.
There are currently 38,493,000 shares in issue with a current share value of 682 giving Intuitive Surgical Inc a market capitalisation of 26.25B USD .
Intuitive Surgical Inc (NASDAQ:ISRG) has a 50 day moving average of 703.09 and a 200 day moving average of 666.36. The 52 week high for the share price is 727.25 while the 52 week low for the stock is 483.11.
Intuitive Surgical, Inc. (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports. The da Vinci Surgical System provides its operating surgeons with control, range of motion, tissue manipulation solution and three-dimensional (3-D), high-definition vision. It allows surgeons to work through the small ports enabled by minimally invasive surgery procedures. Its da Vinci Surgery utilizes computational, robotic and imaging technologies. It focuses on five surgical specialties: gynecologic surgery, urologic surgery, general surgery, cardiothoracic surgery, and head and neck surgery.